Hypersensitivity of the striatal striosomal dopamine D1 receptor-neuron in a rodent model of restless legs syndrome

We hypothesized that Restless Legs Syndrome (RLS) and the restlessness of opioid withdrawal share common neurobiological mechanisms based on the efficacy of µ-opioid receptor (MOR) agonists in RLS and the common RLS-like phenotype of patients with opioid withdrawal. We also hypothesized this involves an increased sensitivity of the striosomal neurons that co-express MORs and dopamine D ₁ receptors (D ₁ Rs) and release GABA in the internal segment of the globus pallidus (GPi). This hypothesis was tested in mice with diet-induced brain iron deficiency (BID), a rodent model of RLS. Fiber-photometry experiments were performed in mice with BID using a viral GABA biosensor injected in the EPN, the GPi equivalent in rodents. EPN GABA release was measured after the systemic administration of the D ₁ R agonist SKF81297 and the MOR agonist methadone. Locomotor activation and striatal mRNA expression of D ₁ Rs, MORs and adenosine A ₁ receptors (A ₁ Rs) were also analyzed. A minimal locomotor-activating dose of SKF81297 induced a significant EPN GABA release in mice with BID but not controls, while a maximal locomotor-activating dose of the MOR agonist methadone significantly reduced EPN GABA release in mice with BID after saline or SKF81297 administration. BID was associated with a significant reduction in the striatal expression of MORs and A ₁ Rs. BID induces an increased sensitivity of the striosomal MOR-D ₁ R neuron, which might represent a pivotal pathogenetic mechanism of the restlessness of RLS and opioid withdrawal. The striosomal MOR-D ₁ R neuron may represent the main target for the therapeutic effect of opioids in RLS.